Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

"Cancer was a speed bump in my path to enlightenment:" A qualitative analysis of situational coping experiences among young adult survivors of childhood cancer.

Foster RH, Brouwer AM, Dillon R, Bitsko MJ, Godder K, Stern M.

J Psychosoc Oncol. 2017 Feb 15:1-16. doi: 10.1080/07347332.2017.1292575. [Epub ahead of print]

PMID:
28332951
2.

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N.

Blood. 2016 Nov 24;128(21):2561-2567. Epub 2016 Sep 13.

PMID:
27625358
3.

One-unit versus two-unit cord-blood transplantation for hematologic cancers.

Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J; Blood and Marrow Transplant Clinical Trials Network..

N Engl J Med. 2014 Oct 30;371(18):1685-94. doi: 10.1056/NEJMoa1405584.

4.

Relations among optimism, perceived health vulnerability, and academic, self-regulatory, and social self-efficacy in adolescent survivors of childhood cancer.

Foster RH, Russell CC, Dillon R, Bitsko MJ, Godder K, Stern M.

J Psychosoc Oncol. 2014;32(2):207-23. doi: 10.1080/07347332.2013.874000.

PMID:
24364903
5.

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma.

Gowda M, Payne KK, Godder K, Manjili MH.

Oncoimmunology. 2013 Oct 1;2(10):e26616. Epub 2013 Oct 10.

6.

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Eckrich MJ, Ahn KW, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M.

Am J Hematol. 2014 Feb;89(2):125-9. doi: 10.1002/ajh.23594. Epub 2013 Nov 15.

7.

Vitamin d deficiency in children with cancer.

Helou M, Ning Y, Yang S, Irvine P, Bachmann LM, Godder K, Massey G.

J Pediatr Hematol Oncol. 2014 Apr;36(3):212-7. doi: 10.1097/MPH.0b013e31829f3754.

PMID:
23823117
8.

Graft-versus-host disease after solid organ transplantation: a single center experience and review of literature.

Sharma A, Armstrong AE, Posner MP, Kimball PM, Cotterell AH, King AL, Fisher RA, Godder K.

Ann Transplant. 2012 Dec 31;17(4):133-9. Review.

PMID:
23274334
9.

Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies.

Bajwa R, Schechter T, Soni S, Gassas A, Doyle J, Sisler I, Godder K, Tatman D, Rumelhart S, Domm J, Miao Y, Frangoul H.

Bone Marrow Transplant. 2013 May;48(5):661-5. doi: 10.1038/bmt.2012.209. Epub 2012 Nov 5.

PMID:
23128573
10.

Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities.

Aygun B, Wruck LM, Schultz WH, Mueller BU, Brown C, Luchtman-Jones L, Jackson S, Iyer R, Rogers ZR, Sarnaik S, Thompson AA, Gauger C, Helms RW, Ware RE; TCD With Transfusions Changing to Hydroxyurea (TWiTCH) Trial Investigators..

Am J Hematol. 2012 Apr;87(4):428-30. doi: 10.1002/ajh.23105. Epub 2012 Jan 9. No abstract available.

11.

Inpatient management of sickle cell pain: a 'snapshot' of current practice.

Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)..

Am J Hematol. 2012 Mar;87(3):333-6. doi: 10.1002/ajh.22265. Epub 2012 Jan 9.

12.

Distinct signatures of the immune responses in low risk versus high risk neuroblastoma.

Gowda M, Godder K, Kmieciak M, Worschech A, Ascierto ML, Wang E, Marincola FM, Manjili MH.

J Transl Med. 2011 Oct 6;9:170. doi: 10.1186/1479-5876-9-170.

13.

Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.

Gilman AL, Schultz KR, Goldman FD, Sale GE, Krailo MD, Chen Z, Langholz B, Jacobsohn DA, Chan KW, Ryan RE, Kellick M, Neudorf SM, Godder K, Sandler ES, Sahdev I, Grupp SA, Sanders JE, Wall DA.

Biol Blood Marrow Transplant. 2012 Jan;18(1):84-91. doi: 10.1016/j.bbmt.2011.05.016. Epub 2011 May 30.

14.

Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW; ICA-17043-10 Study Investigators..

Br J Haematol. 2011 Apr;153(1):92-104. doi: 10.1111/j.1365-2141.2010.08520.x. Epub 2011 Feb 17.

PMID:
21323872
15.

Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

Dreyer ZE, Dinndorf PA, Camitta B, Sather H, La MK, Devidas M, Hilden JM, Heerema NA, Sanders JE, McGlennen R, Willman CL, Carroll AJ, Behm F, Smith FO, Woods WG, Godder K, Reaman GH.

J Clin Oncol. 2011 Jan 10;29(2):214-22. doi: 10.1200/JCO.2009.26.8938. Epub 2010 Dec 6.

16.

Fatigue, sleep-wake disturbances, and quality of life in adolescents receiving chemotherapy.

Erickson JM, Beck SL, Christian BR, Dudley W, Hollen PJ, Albritton KA, Sennett M, Dillon RL, Godder K.

J Pediatr Hematol Oncol. 2011 Jan;33(1):e17-25. doi: 10.1097/MPH.0b013e3181f46a46.

PMID:
21063224
17.

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.

Baker DL, Schmidt ML, Cohn SL, Maris JM, London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A, Shamberger RC, Look AT, Reynolds CP, Seeger RC, Matthay KK; Children’s Oncology Group..

N Engl J Med. 2010 Sep 30;363(14):1313-23. doi: 10.1056/NEJMoa1001527.

18.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Shaw PJ, Kan F, Woo Ahn K, Spellman SR, Aljurf M, Ayas M, Burke M, Cairo MS, Chen AR, Davies SM, Frangoul H, Gajewski J, Gale RP, Godder K, Hale GA, Heemskerk MB, Horan J, Kamani N, Kasow KA, Chan KW, Lee SJ, Leung WH, Lewis VA, Miklos D, Oudshoorn M, Petersdorf EW, Ringdén O, Sanders J, Schultz KR, Seber A, Setterholm M, Wall DA, Yu L, Pulsipher MA.

Blood. 2010 Nov 11;116(19):4007-15. doi: 10.1182/blood-2010-01-261958. Epub 2010 Jul 29.

19.

Patterns of fatigue in adolescents receiving chemotherapy.

Erickson JM, Beck SL, Christian B, Dudley WN, Hollen PJ, Albritton K, Sennett MM, Dillon R, Godder K.

Oncol Nurs Forum. 2010 Jul;37(4):444-55. doi: 10.1188/10.ONF.444-455.

PMID:
20591804
20.

CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer.

Kmieciak M, Worschech A, Nikizad H, Gowda M, Habibi M, Depcrynski A, Wang E, Godder K, Holt SE, Marincola FM, Manjili MH.

Breast Cancer Res Treat. 2011 Apr;126(2):385-94. doi: 10.1007/s10549-010-0942-8. Epub 2010 May 18.

Supplemental Content

Loading ...
Support Center